The direct effects p-cresol has on BBB physiology may be through functional antagonism of the TLR4 complex, a receptor complex activated by LPS [156]
For subcutaneous and intramuscular injection, acetate BPC-157 delivers the full peptide directly into tissues where it can act immediately
Honest framing of what to expect Patients are not promised dramatic skin lightening
Phase 1 (Weeks 1 to 2): 0.25 mg subcutaneous injection once daily, morning on empty stomach Phase 2 (Weeks 3 to 6): Maintain 0.25 mg or increase to 0.5 mg based on response and tolerance Phase 3 (Weeks 7 to 8): Continue or begin taper depending on symptom improvement Maintenance: Consider cycling 4 weeks on, 2 weeks off for long-term management Oral dosing requires higher amounts to compensate for bioavailability differences
38 also used another LH-RH agonist, d-Leu6, Pro9-NHEt-LH-RH (Lupron, Abbott-Takeda) 38 for 46 months, reporting a reduction in prostate size and improvement in 15 men with BPH 38